From 1 September 2026, the prescriber accreditation requirement for hepatitis B medicines under the PBS Section 100 (s100) Highly Specialised Drugs Program will be removed. As a result, all medical and authorised nurse practitioners will be able to prescribe hepatitis B antiviral treatment without additional specialist accreditation. ASHM is currently updating its website, education and resources to reflect this change.

Find out more

HIV and Hepatitis Co-infections

Delivery mode
Live Online
CPD Hours
1
Total Prescriber Points
2
Cost
FREE
26 Nov, 6:00pm AWST
Online (WA)

Overview

As HIV treatment evolves and simplified treatment regimens become more common, understanding the implications of viral hepatitis co-infection is increasingly important. This webinar will provide a practical update on hepatitis B, hepatitis D and hepatitis C in people living with HIV, with a particular focus on treatment decision-making and avoiding unintended consequences when modifying antiretroviral therapy.

Drawing on recent clinical evidence and case studies, the session will explore hepatitis B reactivation risks, considerations when switching from tenofovir-containing regimens, and best-practice approaches to managing viral hepatitis co-infections in primary care and specialist settings.

Date, Time, Platform:

  • Date: Thursday 26 November 2026
  • Time: 6:00pm – 7:00pm (AWST)
  • Platform: Live Online – Zoom

Speakers:

  • Adam Gregson | Nurse Practitioner | Royal Perth Hospital 

CPD and Endorsement:

Endorsement is currently pending with RACGP and ACRRM. This activity may be suitable for self-claiming CPD hours with your professional body. An estimated equivalent of 1 CPD hours applies. A statement of attendance will be provided for full attendees.

Accredited HIV Prescribers attending in full will also receive 2 HIV Prescriber Points.

Funding:

This activity is funded by Western Australian Department of health.

Target Audience:

HIV and HBV s100 prescribers based in WA.

For more information:

Please contact ASHM Education at [email protected] or call 0431 320 429.

Third-party software or any recording tools are not permitted during this event unless expressly authorised by ASHM. This requirement supports participant privacy, confidentiality, and compliance with ASHM's Acceptable Use of AI requirements. Please note some sessions may be recorded by ASHM as part of our quality assurance and funder requirements.

Upcoming Conferences and Events

Sector Event

The AAAH Youth Health Conference 2027

5 - 7 May 2027
Qt Hotel Gold Coast on Yugambeh Country (QLD, Australia)

17th Australasian Viral Hepatitis Conference

18 - 20 Aug 2027
Novotel Wollongong Northbeach, Wollongong, on the traditional lands of the Dharawal people (NSW, Australia)
Sector Event

15th International Conference on Health, Hepatitis, and Substance Use

7 - 10 Sep 2027
Mexico City (Mexico)